Bank Of America Corp Protagonist Therapeutics, Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Bank Of America Corp holds 300,481 shares of PTGX stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300,481

Previous 228,440 31.54%

Holding current value

$14 Million

Previous $6.61 Million 57.55%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.66 - $34.8 $1.78 Million - $2.51 Million	72,041 Added 31.54%	300,481 $10.4 Million
Q1 2024 May 15, 2024	BUY	$21.79 - $32.15 $1.63 Million - $2.41 Million	75,031 Added 48.91%	228,440 $6.61 Million
Q4 2023 Feb 14, 2024	SELL	$14.05 - $23.44 $2.01 Million - $3.35 Million	-142,831 Reduced 48.21%	153,409 $3.52 Million
Q2 2023 Aug 14, 2023	SELL	$18.02 - $29.36 $8.48 Million - $13.8 Million	-470,750 Reduced 61.38%	296,240 $8.18 Million
Q1 2023 May 12, 2023	BUY	$10.78 - $25.38 $4.55 Million - $10.7 Million	422,043 Added 122.35%	766,990 $17.6 Million
Q4 2022 Feb 10, 2023	BUY	$7.36 - $11.17 $256,849 - $389,810	34,898 Added 11.26%	344,947 $3.76 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $22,157 - $33,010	2,819 Added 0.92%	310,049 $2.61 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $25.52 $419,039 - $1.51 Million	59,354 Added 23.95%	307,230 $2.43 Million
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $2.99 Million - $4.63 Million	128,269 Added 107.24%	247,876 $5.87 Million
Q4 2021 Feb 08, 2022	BUY	$17.63 - $37.1 $1.09 Million - $2.3 Million	61,956 Added 107.47%	119,607 $4.09 Million
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $104,661 - $401,594	-8,082 Reduced 12.3%	57,651 $1.02 Million
Q2 2021 Sep 13, 2021	BUY	$25.57 - $44.88 $1.68 Million - $2.95 Million	65,733 New	65,733 $2.95 Million

Others Institutions Holding PTGX

# of Institutions

222

Shares Held

59.3M

Call Options Held

19K

Put Options Held

107K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.28B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Protagonist Therapeutics, Inc Transaction History